LevelUp Rx sells sermorelin, NAD+ and glutathione behind product copy that is, paragraph for paragraph, the same copy another seller on this roster publishes — and it charges roughly double for it. Neither its about page, its terms nor its privacy policy names a company that operates it.
What LevelUp Rx charges
Sermorelin: $195 — the single figure printed beneath a "1 Month Supply / 3 Month Supply" selector, attributed in the visible text to neither term — so it cannot be read as a monthly rate
NAD+: $199 — starting at, with "Per month" printed beneath it — a floor rather than a quoted bill, on a page whose tagline is byte-identical to another roster seller's NAD+ page carrying a much lower figure the same day
Glutathione: $57.32 — starting at, with no billing period stated anywhere on the page
LevelUp Rx is not a paid partner; this link may earn a commission if that changes. Full disclosure.
By Nora Castellan, Standards EditorUpdated September 2026
The same paragraphs, at a different price
Its sermorelin page and another roster seller's sermorelin page were fetched in the same run and compared node by node. Of the thirty substantial paragraphs on this seller's page, twenty-three appear byte-identical on the other, including the clinical explanation of why the compound stimulates rather than replaces, the passage on recovery and body composition, and the safety line about prescriptions being overseen by licensed physicians.
The NAD+ pages carry the same tagline as each other, word for word. That tagline is a marketing phrase specific enough that two unrelated companies arriving at it independently is not a plausible reading.
The prices are not the same. On both NAD+ and sermorelin the figure here is roughly double the other seller's, read on the same day, from each company's own product page, with a control run on each host.
This site records both rows and says plainly that they are not independent observations. A board that treats them as two separate readings of what the market charges would be counting one catalogue twice.
A price that a careless reader would have missed entirely
The sermorelin figure is fully published and plainly visible, but the markup splits the currency symbol into one element and the digits into the next. An extractor that matches a currency symbol followed by a number inside a single text node finds nothing at all on this page.
That failure produces a false claim that the seller publishes no price — the single claim this site is most careful never to make wrongly. The figures here were read from the joined text of the whole page for exactly that reason, and the extractor was tested against a constructed split-price page before it was pointed at a real one.
The figure it does publish sits beneath a selector offering a one-month supply and a three-month supply, with one price and no statement of which term it belongs to. This site records it as a figure that is not a monthly rate.
The other two peptide pages each print a starting figure with no billing period attached. Neither says what the ongoing charge is.
Nobody is named as the counterparty
The about page, the terms and the privacy policy were read in full — a little over fifty thousand characters between them — and searched for bare corporate suffixes rather than for a company-name pattern, because a pattern finds what it was shaped to find.
Three corporate-suffix tokens appear across all three documents. One is the arbitration provider named in a standard dispute clause. One is an analytics vendor named in the privacy policy. The third occurrence is the same arbitration clause again. The about page contains none.
So there is no operating company published anywhere a buyer would look. That is a censused absence with the character counts attached, not an inference from a regex returning nothing.
For contrast, the seller whose copy this matches does name corporate entities on its own product page — a telehealth platform vendor and two affiliated practices. Those are the platform, not necessarily the operator either, but they are at least names a reader can follow.
What the site does and does not answer
The pages make the usual telehealth claims: online consultation, licensed providers, no insurance required, discreet shipping. None of those is specific enough to check.
No compounding pharmacy is named on any page read. No state coverage list is published. Nothing describes lab work as included at any price.
No certificate of analysis, purity report or third-party testing claim appears in the text of any page read here.
The catalogue is broad rather than deep — hair loss, birth control, smoking cessation, acid reflux and a growth-hormone lane sit in the same navigation. The peptide products are three items inside a general telehealth storefront.
Who it's for
Readers who want to see what happens to a price when the same clinical catalogue is sold under a second brand.
Buyers who only need a figure on the page and are not asking who stands behind it.
Anyone shopping a general telehealth storefront where peptides sit alongside unrelated conditions.
Who should look elsewhere
Anyone who wants to know which company they are buying from, which no page here answers.
Readers who want the price attached to a stated supply length rather than to a selector offering two.
Buyers who need the dispensing pharmacy named.
Shoppers who want to know whether the service reaches their state.
Anyone comparing sellers on value, given that the identical copy is published elsewhere for substantially less.
Strengths
Every product page carries a figure in visible body text, with no account gate and no blur
The catalog is grouped by condition, so the peptide lane is reachable in one click from any page
The three peptide pages each print their figure in the same place and the same shape
Trade-offs
No operating company appears anywhere on its about, terms or privacy pages — the only corporate names on them are the arbitration provider and an analytics vendor
Its sermorelin page shows a one-month and a three-month option with a single price attached to neither
Twenty-three of its thirty substantial sermorelin paragraphs are byte-identical to another seller on this roster, so the two rows are not independent readings of the market
No compounding pharmacy is named, no state list is published, and no certificate of analysis appears on any page read
How we verified this
Loaded three product pages and three legal pages with a full browser user-agent, printed the effective URL beside the requested URL on every fetch, and confirmed none redirected.
Ran a nonsense-path control on the host in the same run and confirmed a not-found response, so a host that answers for any path could not be mistaken for a real page.
Used the URL recorded in the research note rather than deriving one from a pattern; a shortened form of that path returns not-found and would have falsely disproved a true claim.
Joined the page's text nodes before matching any price. A per-node matcher finds zero figures on the sermorelin page, because the currency symbol and the digits sit in different elements.
Bite-tested that matcher on a constructed split-price page in both directions before trusting it on a live one.
Fetched the other seller's comparable page in the same run and compared every text node of forty characters or more for byte equality, rather than judging similarity by eye.
Confirmed the other seller's roster row carries the same verification date, so the price gap is a same-day comparison rather than a stale one.
Searched all three legal pages for bare corporate suffixes rather than for a company-name pattern, and recorded the character count of each document searched.
Read the sentence around every corporate-name hit rather than counting the hits, which is how the arbitration provider and the analytics vendor were identified as such.
A provider to compare LevelUp Rx against
Trellis Vitality
Trellis Vitality frames its program around body-composition tracking rather than scale weight, pairing NAD+, glutathione and tesamorelin with at-home biomarker panels and a 90-day re-test, and names its dispensing pharmacy, VialsRX in Houston, by address.
Is this the same company as the seller whose copy it matches?
This site does not assert that. What was measured is that twenty-three of thirty substantial paragraphs on one page are byte-identical, and that the NAD+ tagline is the same phrase. Neither company publishes an operating entity that would settle the question.
Which is cheaper?
The other seller, on both compounds where the two overlap, read on the same day from each company's own page. The figures and their qualifiers sit on the two roster rows.
Does the sermorelin price cover one month or three?
The page does not say. It shows a selector with both options and a single figure attached to neither, which is why this site does not record it as a monthly rate.
Who operates the site?
No page answers that. Across the about page, the terms and the privacy policy, the only corporate names are an arbitration provider and an analytics vendor.
Is there a certificate of analysis?
None appears in the text of any page read.
LevelUp Rx is not a paid partner; this link may earn a commission if that changes. Full disclosure.